01 1Taro Pharmaceutical Industries
01 1HYDROCORTISONE 17-BUTYRATE USP, MICRONIZED
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-01-24
Pay. Date : 2015-03-06
DMF Number : 15750
Submission : 2001-12-06
Status : Active
Type : II
20
Taro Pharmaceutical Industries Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is HYDROCORTISONE 17-BUTYRATE USP, MICRONIZED, with a corresponding US DMF Number 15750.
Remarkably, this DMF maintains an Active status since its submission on December 06, 2001, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 24, 2018, and payment made on March 06, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
